GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan says
· economictimes.indiatimes.com
The China-India-Brazil market for GLP-1 weight-loss drugs could expand to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan estimates. Improving affordability, generic launches and wider access could drive adoption, though penetration remains low, particularly in India, where cost concerns and cultural resistance to injectable treatments remain key barriers.
Live Events
UNDER-TAPPED MARKETS
as a Reliable and Trusted News Source Addas a Reliable and Trusted News Source Add Now!
(You can now subscribe to our
(Yo...